Susan Hasty, Publisher
Table of Contents . . . September 13th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Depression - Sertraline safe for patients with recent heart attack or unstable angina
Gastrointestinal Stromal Tumors - Gleevec's effectiveness on untreatable cancer shown
Breast Cancer - Xyotax studies initiated for ovarian, breast cancers
Dysmenorrhea - COX-2 specific inhibitor Bextra effective, well-tolerated treatment
Gastroenterology - Results released from CDP 571 phase III studies in Crohn disease
Mucositis - OraPharma reports favorable results from phase I trial of OC-1012
Therapy - Potent experimental drug shown to slow the growth of breast and prostate cancer tumors in mice
Allergy Medicine - Schering-Plough to appeal district court ruling on Claritin patent
Bacterial Prostatitis - Ortho-McNeil submits supplemental new drug application for Levaquin
Gastroesophageal Reflux Disease - TAP Pharmaceutical gets FDA approval for pediatric labeling of Prevacid
Gaucher Disease - Israel to end temporary suspension of Vevesca (OGT 918) trials
Gaucher Disease - OGS Announces Positive CPMP Opinion for Zavesca
HIV/AIDS Therapy - Low-dose paclitaxel effective for high-risk Kaposi sarcoma patients
Healthcare Insurance - California representatives cross party lines to back increase for AIDS drugs
Herpes - Powerful new genital herpes drug studied at MCG
Legal Issues - Eli Lilly subpoenaed over marketing of osteoporosis drug
Mergers and Acquisitions - Genesis Health Ventures to acquire NCS HealthCare
Osteoporosis - Apomine trial started in postmenopausal women
Prostate Cancer - FDA approves Eligard 22.5 mg
Solid Tumors - ILEX initiates phase I Clofarex study
Thyroid Disease - Synthroid wins FDA approval
Tuberculosis Therapy - Hearing loss may be long-term sequela of aminoglycoside use
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.